364 related articles for article (PubMed ID: 9132005)
1. Physical studies of conformational plasticity in a recombinant prion protein.
Zhang H; Stockel J; Mehlhorn I; Groth D; Baldwin MA; Prusiner SB; James TL; Cohen FE
Biochemistry; 1997 Mar; 36(12):3543-53. PubMed ID: 9132005
[TBL] [Abstract][Full Text] [Related]
2. High-level expression and characterization of a purified 142-residue polypeptide of the prion protein.
Mehlhorn I; Groth D; Stöckel J; Moffat B; Reilly D; Yansura D; Willett WS; Baldwin M; Fletterick R; Cohen FE; Vandlen R; Henner D; Prusiner SB
Biochemistry; 1996 Apr; 35(17):5528-37. PubMed ID: 8611544
[TBL] [Abstract][Full Text] [Related]
3. Molecular model of an alpha-helical prion protein dimer and its monomeric subunits as derived from chemical cross-linking and molecular modeling calculations.
Kaimann T; Metzger S; Kuhlmann K; Brandt B; Birkmann E; Höltje HD; Riesner D
J Mol Biol; 2008 Feb; 376(2):582-96. PubMed ID: 18158160
[TBL] [Abstract][Full Text] [Related]
4. In vitro conversion of full-length mammalian prion protein produces amyloid form with physical properties of PrP(Sc).
Bocharova OV; Breydo L; Parfenov AS; Salnikov VV; Baskakov IV
J Mol Biol; 2005 Feb; 346(2):645-59. PubMed ID: 15670611
[TBL] [Abstract][Full Text] [Related]
5. Solution structure of Syrian hamster prion protein rPrP(90-231).
Liu H; Farr-Jones S; Ulyanov NB; Llinas M; Marqusee S; Groth D; Cohen FE; Prusiner SB; James TL
Biochemistry; 1999 Apr; 38(17):5362-77. PubMed ID: 10220323
[TBL] [Abstract][Full Text] [Related]
6. Structural intermediates in the putative pathway from the cellular prion protein to the pathogenic form.
Jansen K; Schäfer O; Birkmann E; Post K; Serban H; Prusiner SB; Riesner D
Biol Chem; 2001 Apr; 382(4):683-91. PubMed ID: 11405232
[TBL] [Abstract][Full Text] [Related]
7. X-ray diffraction analysis of scrapie prion: intermediate and folded structures in a peptide containing two putative alpha-helices.
Inouye H; Kirschner DA
J Mol Biol; 1997 May; 268(2):375-89. PubMed ID: 9159477
[TBL] [Abstract][Full Text] [Related]
8. The structural transition of the prion protein into its pathogenic conformation is induced by unmasking hydrophobic sites.
Leffers KW; Schell J; Jansen K; Lucassen R; Kaimann T; Nagel-Steger L; Tatzelt J; Riesner D
J Mol Biol; 2004 Nov; 344(3):839-53. PubMed ID: 15533449
[TBL] [Abstract][Full Text] [Related]
9. The N-terminal domain of the enzyme I is a monomeric well-folded protein with a low conformational stability and residual structure in the unfolded state.
Romero-Beviar M; Martínez-Rodríguez S; Prieto J; Goormaghtigh E; Ariz U; Martínez-Chantar Mde L; Gómez J; Neira JL
Protein Eng Des Sel; 2010 Sep; 23(9):729-42. PubMed ID: 20630900
[TBL] [Abstract][Full Text] [Related]
10. Polypeptide chain folding in the hydrophobic core of hamster scrapie prion: analysis by X-ray diffraction.
Inouye H; Kirschner DA
J Struct Biol; 1998; 122(1-2):247-55. PubMed ID: 9724626
[TBL] [Abstract][Full Text] [Related]
11. Structural changes of the prion protein in lipid membranes leading to aggregation and fibrillization.
Kazlauskaite J; Sanghera N; Sylvester I; Vénien-Bryan C; Pinheiro TJ
Biochemistry; 2003 Mar; 42(11):3295-304. PubMed ID: 12641461
[TBL] [Abstract][Full Text] [Related]
12. Slow conformational dynamics in the hamster prion protein.
Kuwata K; Kamatari YO; Akasaka K; James TL
Biochemistry; 2004 Apr; 43(15):4439-46. PubMed ID: 15078089
[TBL] [Abstract][Full Text] [Related]
13. Spectroscopic characterization of conformational differences between PrPC and PrPSc: an alpha-helix to beta-sheet transition.
Baldwin MA; Pan KM; Nguyen J; Huang Z; Groth D; Serban A; Gasset M; Mehlhorn I; Fletterick RJ; Cohen FE
Philos Trans R Soc Lond B Biol Sci; 1994 Mar; 343(1306):435-41. PubMed ID: 7913763
[TBL] [Abstract][Full Text] [Related]
14. The role of the 132-160 region in prion protein conformational transitions.
Torrent J; Alvarez-Martinez MT; Liautard JP; Balny C; Lange R
Protein Sci; 2005 Apr; 14(4):956-67. PubMed ID: 15772306
[TBL] [Abstract][Full Text] [Related]
15. Prion protein alpha-to-beta transition monitored by time-resolved Fourier transform infrared spectroscopy.
Ollesch J; Künnemann E; Glockshuber R; Gerwert K
Appl Spectrosc; 2007 Oct; 61(10):1025-31. PubMed ID: 17958950
[TBL] [Abstract][Full Text] [Related]
16. Preventing misfolding of the prion protein by trimethylamine N-oxide.
Bennion BJ; DeMarco ML; Daggett V
Biochemistry; 2004 Oct; 43(41):12955-63. PubMed ID: 15476389
[TBL] [Abstract][Full Text] [Related]
17. Induction of alpha-helix in the beta-sheet protein tumor necrosis factor-alpha: thermal- and trifluoroethanol-induced denaturation at neutral pH.
Narhi LO; Philo JS; Li T; Zhang M; Samal B; Arakawa T
Biochemistry; 1996 Sep; 35(35):11447-53. PubMed ID: 8784200
[TBL] [Abstract][Full Text] [Related]
18. Molecular properties of complexes formed between the prion protein and synthetic peptides.
Kaneko K; Wille H; Mehlhorn I; Zhang H; Ball H; Cohen FE; Baldwin MA; Prusiner SB
J Mol Biol; 1997 Jul; 270(4):574-86. PubMed ID: 9245588
[TBL] [Abstract][Full Text] [Related]
19. Structural dependence of the cellular isoform of prion protein on solvent: spectroscopic characterization of an intermediate conformation.
Pergami P; Bramanti E; Ascoli GA
Biochem Biophys Res Commun; 1999 Nov; 264(3):972-8. PubMed ID: 10544040
[TBL] [Abstract][Full Text] [Related]
20. Conformational properties of peptide fragments homologous to the 106-114 and 106-126 residues of the human prion protein: a CD and NMR spectroscopic study.
Di Natale G; Impellizzeri G; Pappalardo G
Org Biomol Chem; 2005 Feb; 3(3):490-7. PubMed ID: 15678187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
